Nephrol Dial Transplant (2002) 17: 28-32
© 2002 European Renal Association-European Dialysis and Transplant Association
Dialysis and Transplantation News
The epidemiology of end-stage renal disease in Iran in an international perspective
1 Taleghani University Hospital, Shahid Beheshti Medical Sciences University, Tehran, Iran, 2 Rasoul Akram University Hospital, University of Medical Sciences of Iran, Tehran, Iran, 3 Azienda Ospedale di Lecco, A. Manzoni Hospital, Lecco, Italy and 4 Department of Nephrology, University of Heidelberg, Heidelberg, Germany
Abstract
Introduction. The epidemiology of end-stage renal disease (ESRD) and renal replacement therapy (RRT) is under continuous evolution all over the world. We report here the epidemiological analysis of ESRD and RRT in Iran and discuss it against the background of the international situation.
Methods. This epidemiological report is based on data from centre questionnaires which were collected in Iran from 1997 onwards, with a response rate of 100%.
Results. The prevalence/incidence of RRT patients were 238/49.9 p.m.p. in the year 2000. Haemodialysis and kidney transplantation were the most common RRT modalities, accounting for 53.7% and 45.5% of prevalent RRT patients, respectively. The proportion treated by peritoneal dialysis was very low (<1%). Home haemodialysis was not performed. The majority of haemodialysis centres used synthetic membranes (70%) and 100% of the sessions were performed using acetate as a buffer; 42.5% of haemodialysis patients were treated with a twice-weekly regimen, whilst 49.6% were on the standard thrice-weekly regimen. The majority of RRT patients in Iran were young to middle aged. The great majority of renal allografts came from living donors (mainly unrelated to recipients). The main renal diseases leading to ESRD were diabetes and hypertension. The third most common category was ‘cause unknown’.
Conclusion. The epidemiology of RRT in Iran is characterized by: (i) young patient age (younger than the international average); (ii) high proportion of patients receiving renal allograft; (iii) use of living-unrelated donors as the major source of renal allografts.
Notes
* Data of the Dialysis and Transplantation Symposium Joint Meeting, Tehran, 28–30 April 2001.
Correspondence and offprint requests to: Prof. Dr Francesco Locatelli, Department of Nephrology and Dialysis, Ospedale A. Manzoni, Via Dell'Eremo 9/11, I-23900 Lecco, Italy. Email: nefrologia{at}ospedale.lecco.it
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Fishbane, W. B. Shapiro, D. B. Corry, S. L. Vicks, M. Roppolo, K. Rappaport, X. Ling, W. G. Goodman, S. Turner, and C. Charytan Cinacalcet HCl and Concurrent Low-dose Vitamin D Improves Treatment of Secondary Hyperparathyroidism in Dialysis Patients Compared with Vitamin D Alone: The ACHIEVE Study Results Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1718 - 1725. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-C. Szeto, B. C.-H. Kwan, K.-M. Chow, K.-B. Lai, K.-Y. Chung, C.-B. Leung, and P. K.-T. Li Endotoxemia is Related to Systemic Inflammation and Atherosclerosis in Peritoneal Dialysis Patients Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 431 - 436. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mahdavi-Mazdeh, M. Zamyadi, and M. Nafar Assessment of management and treatment responses in haemodialysis patients from Tehran province, Iran Nephrol. Dial. Transplant., January 1, 2008; 23(1): 288 - 293. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Bezuidenhout, M. Bracher, G. Davison, P. Zilla, and N. Davies Ang-2 and PDGF-BB cooperatively stimulate human peripheral blood monocyte fibrinolysis J. Leukoc. Biol., June 1, 2007; 81(6): 1496 - 1503. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. C.Y. Tong, A. P.S. Kong, W.-Y. So, M. H.L. Ng, X. Yang, M. C.Y. Ng, R. C.W. Ma, C.-S. Ho, C. W.K. Lam, C.-C. Chow, et al. Hematocrit, independent of chronic kidney disease, predicts adverse cardiovascular outcomes in chinese patients with type 2 diabetes. Diabetes Care, November 1, 2006; 29(11): 2439 - 2444. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. V. Mukhin, M. Gooz, J. R. Raymond, and M. N. Garnovskaya Collagenase-2 and -3 Mediate Epidermal Growth Factor Receptor Transactivation by Bradykinin B2 Receptor in Kidney Cells J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1033 - 1043. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. B. Drueke Haematopoietic stem cells--role of calcium-sensing receptor in bone marrow homing Nephrol. Dial. Transplant., August 1, 2006; 21(8): 2072 - 2074. [Full Text] [PDF]
|
|
|
|
|
|
C. Ulrich, G. H. Heine, P. Garcia, B. Reichart, T. Georg, M. Krause, H. Kohler, and M. Girndt Increased expression of monocytic angiotensin-converting enzyme in dialysis patients with cardiovascular disease Nephrol. Dial. Transplant., June 1, 2006; 21(6): 1596 - 1602. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Bammens, P. Evenepoel, K. Verbeke, and Y. Vanrenterghem Impairment of small intestinal protein assimilation in patients with end-stage renal disease: extending the malnutrition-inflammation-atherosclerosis concept Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1536 - 1543. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Mesic, H. Resic, A. Halilbasic, I. Komljenovic, M. Vasilj, L. Vucicevic, and S. Trnacevic Renal replacement therapy in Bosnia and Herzegovina: report of the Society of Nephrology, Dialysis and Transplantation of Bosnia and Herzegovina Nephrol. Dial. Transplant., April 1, 2003; 18(4): 661 - 663. [Full Text] [PDF]
|
|